Roberto Vicini

8PUBLICATIONS
45CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPacific Peoples nursing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 18, 2024
Colchicine treatment in amyotrophic lateral sclerosis: safety, biological and clinical effects in a randomized clinical trial.

Giulia Gianferrari, Riccardo Cuoghi Costantini, Valeria Crippa

|Sep 25, 2023
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial.

PierFranco Conte, Giancarlo Bisagni, Federico Piacentini

|Sep 07, 2023
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer.

Maria Vittoria Dieci, PierFranco Conte, Giancarlo Bisagni

|Aug 17, 2023
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis.

Jessica Mandrioli, Roberto D'Amico, Elisabetta Zucchi

|Apr 12, 2023
Author Correction: Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial.

Maria Vittoria Dieci, Giancarlo Bisagni, Stefania Bartolini

|Feb 04, 2023
Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial.

Maria Vittoria Dieci, Giancarlo Bisagni, Stefania Bartolini

Pageof 2

Frequent Collaborators

4 joint publications

Valentina Guarneri

4 joint publications

Maria Vittoria Dieci

3 joint publications

Sara Balduzzi

3 joint publications

Antonio Frassoldati